Additional information was received from a business partner on 2017-mar-09.
Information regarding the patient having an infection at the spine and implant site, a fever of greater than 105 degrees fahrenheit, being very sick, having a staph infection that was diagnosed with blood work and treated with intravenous antibiotics and oral antibiotics which resulted in a device explant was re-reported.
It was also reported that the patient experienced muscular weakness in their left arm in (b)(6) 2008.
The patient¿s relevant history includes pain in their left arm and left leg, non-malignant pain, and reflect sympathetic dystrophy/causalgia-complex regional pain syndrome.
On (b)(6) 2009, a new device was implanted after the infection was resolved.
As of (b)(6) 2016, the only drug the patient took was ibuprofen of an unknown concentration, route, dose, and frequency of use.
On (b)(6) 2017, the business partner learned that the patient was a white female with a medical history that included crps (complex regional pain syndrome) was of the left arm and left leg.
The patient¿s concomitant products included: cymbalta (duloxetine hydrochloride) 60 md/day,lipitor (atorvastatin calcium) 80 mg/day, zetia (ezetimibe), asa (acetylsalicylic acid), oxycontin (oxycodone), neurontin(gabapentin) 300 mg 4x/day and niaspan er (niacin extended release), dates of therapy, routes, doses and frequency of use were not reported, when not indicated.
No further complications were reported/are anticipated.
|